By expenditures
| Name | Title | Type |
|---|---|---|
| Tonya C. Frye | Chief Financial Officer | Auditee |
| Daniel Gougherty | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 351621 | 2024 | 2025-03-31 | Cherry Bekaert LLP | $3.78M |
| 306553 | 2023 | 2024-05-17 | Cherry Bekaert LLP | $2.24M |
| 54287 | 2022 | 2023-06-29 | Cherry Bekaert LLP | $2.27M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 351621 | 2024 | 2025-03-31 | 1123814 | 2024-004 | Material Weakness | - | AB |
| 351621 | 2024 | 2025-03-31 | 1123813 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 1123812 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 1123811 | 2024-004 | Material Weakness | - | AB |
| 351621 | 2024 | 2025-03-31 | 1123810 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 1123809 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 1123808 | 2024-004 | Material Weakness | - | AB |
| 351621 | 2024 | 2025-03-31 | 1123807 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 1123806 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 1123805 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 1123804 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 1123803 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 1123802 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 547372 | 2024-004 | Material Weakness | - | AB |
| 351621 | 2024 | 2025-03-31 | 547371 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 547370 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 547369 | 2024-004 | Material Weakness | - | AB |
| 351621 | 2024 | 2025-03-31 | 547368 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 547367 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 547366 | 2024-004 | Material Weakness | - | AB |
| 351621 | 2024 | 2025-03-31 | 547365 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 547364 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 547363 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 547362 | 2024-002 | Significant Deficiency | Yes | L |
| 351621 | 2024 | 2025-03-31 | 547361 | 2024-003 | Significant Deficiency | - | I |
| 351621 | 2024 | 2025-03-31 | 547360 | 2024-002 | Significant Deficiency | Yes | L |
| 306553 | 2023 | 2024-05-17 | 974143 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 974142 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 974141 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 974140 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 974139 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 974138 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 974137 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 974136 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 974135 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 974134 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 397701 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 397700 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 397699 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 397698 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 397697 | 2023-003 | Material Weakness | - | I |
| 306553 | 2023 | 2024-05-17 | 397696 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 397695 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 397694 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 397693 | 2023-002 | Significant Deficiency | - | L |
| 306553 | 2023 | 2024-05-17 | 397692 | 2023-002 | Significant Deficiency | - | L |